R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, pp.987-996, 2005.

M. E. Hegi, A. C. Diserens, T. Gorlia, M. F. Hamou, N. De-tribolet et al., MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, vol.352, pp.997-1003, 2005.

S. Bao, Q. Wu, R. E. Mclendon, Y. Hao, Q. Shi et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.444, pp.756-760, 2006.

C. Ke, K. Tran, Y. Chen, D. Donato, A. T. Yu et al., Linking differential radiation responses to glioma heterogeneity, Oncotarget, vol.5, pp.1657-1665, 2014.

H. K. Shu, M. M. Kim, P. Chen, F. Furman, C. M. Julin et al., The intrinsic radioresistance of glioblastomaderived cell lines is associated with a failure of p53 to induce p21(BAX) expression, Proc Natl Acad Sci, vol.95, pp.14453-14458, 1998.

Y. Kim, K. H. Kim, J. Lee, M. Kim, S. J. Lee et al., Wnt activation is implicated in glioblastoma radioresistance, Lab Invest, vol.92, pp.466-473, 2012.

J. Wang, T. P. Wakeman, J. D. Lathia, A. B. Hjelmeland, X. F. Wang et al., Notch promotes radioresistance of glioma stem cells, Stem Cells, vol.28, pp.17-28, 2010.

A. Chakravarti, A. Dicker, and M. Mehta, The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data, Int J Radiat Oncol Biol Phys, vol.58, pp.927-931, 2004.

J. C. Anderson, C. W. Duarte, K. Welaya, T. D. Rohrbach, M. Bredal et al., Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines, Radiother Oncol, vol.111, pp.468-474, 2014.

L. Galluzzi, O. Kepp, and G. Kroemer, Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy, Oncogene, vol.31, pp.2805-2808, 2012.

Q. Huang, F. Li, X. Liu, W. Li, W. Shi et al., Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy, Nat Med, vol.17, pp.860-866, 2011.

H. Sheng, J. Shao, J. D. Morrow, R. D. Beauchamp, and R. N. Dubois, Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells, Cancer Res, vol.58, pp.362-366, 1998.

L. Lalier, P. F. Cartron, F. Pedelaborde, C. Olivier, D. Loussouarn et al., Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme, Oncogene, vol.26, pp.4999-5009, 2007.

L. Lalier, P. F. Cartron, C. Olivier, C. Logé, G. Bougras et al., Prostaglandins antagonistically control Bax activation during apoptosis, Cell Death Differ, vol.18, pp.528-537, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00587969

L. Lalier, F. Pedelaborde, C. Braud, J. Menanteau, F. M. Vallette et al., Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cells, BMC Cancer, vol.11, p.153, 2011.

R. G. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cell Death Dis, vol.17, p.421, 2010.

K. Andreasson, Emerging roles of PGE2 receptors in models of neurological disease, Prostaglandins Other Lipid Mediat, vol.91, pp.104-112, 2010.

J. Jiang and R. Dingledine, Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection, Trends Pharmacol Sci, vol.34, pp.413-423, 2013.

F. Li, Q. Huang, J. Chen, Y. Peng, D. R. Roop et al., Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration, Sci Signal, vol.3, p.13, 2010.

R. Pai, B. Soreghan, I. L. Szabo, M. Pavelka, D. Baatar et al., Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy, Nat Med, vol.8, pp.289-293, 2002.

J. Shao, B. M. Evers, and H. Sheng, Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells, J Biol Chem, vol.279, pp.14287-14293, 2004.

O. Söderberg, K. J. Leuchowius, M. Gullberg, M. Jarvius, I. Weibrecht et al., Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay, Methods, vol.45, pp.227-232, 2008.

X. Liang, Y. H. So, J. Cui, K. Ma, X. Xu et al., The low-dose ionizing radiation stimulates cell proliferation via activation of the MAPK/ERK pathway in rat cultured mesenchymal stem cells, J Radiat Res, vol.53, pp.380-386, 2011.

B. Li, M. Yuan, I. A. Kim, C. M. Chang, E. J. Bernhard et al., Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin, Oncogene, vol.23, pp.4594-4602, 2004.

M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis, Science, vol.310, pp.1504-1510, 2005.

C. Gratas, Q. Séry, M. Rabé, L. Oliver, and F. M. Vallette, Bak and Mcl-1 are essential for temozolomide induced cell death in human glioma, Oncotarget, vol.5, pp.2428-2435, 2014.

J. J. Kim and I. F. Tannock, Repopulation of cancer cells during therapy: an important cause of treatment failure, Nat Rev Cancer, vol.5, pp.516-525, 2005.

J. F. Fowler, Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked, Radiother Oncol, vol.22, pp.156-158, 1991.

L. Witte, Z. Fuks, A. Haimovitz-friedman, I. Vlodavsky, D. S. Goodman et al., Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells, Cancer Res, vol.49, pp.5066-5072, 1989.

D. M. Higgins, R. Wang, B. Milligan, M. Schroeder, B. Carlson et al., Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts, Oncotarget, vol.4, pp.792-801, 2013.

E. M. Durand and L. I. Zon, Newly emerging roles for prostaglandin E2 regulation of hematopoiesis and hematopoietic stem cell engraftment, Curr Opin Hematol, vol.17, pp.308-320, 2010.

D. Mukherjee, P. J. Coates, S. A. Lorimore, and E. G. Wright, Responses to ionizing radiations mediated by inflammatory mechanisms, J. Pathol, vol.232, pp.289-299, 2014.

P. A. Ohneseit, G. Krebiehl, K. Dittmann, R. Kehlbach, and H. P. Rodemann, Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro, Radiother Oncol, vol.82, pp.229-238, 2007.

K. Xu, L. Wang, and H. Shu, COX-2 overexpression increases malignant potential of human glioma cells through Id1, Oncotarget, vol.5, pp.1241-1252, 2013.